AAAAAA

   
Results: 1-11 |
Results: 11
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients
Authors: Di Paolo, A Danesi, R Falcone, A Cionini, L Vannozzi, F Masi, G Allegrini, G Mini, E Bocci, G Conte, PF Del Tacca, M
Citation: A. Di Paolo et al., Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients, ANN ONCOL, 12(9), 2001, pp. 1301-1306
Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients
Authors: Falcone, A Di Paolo, A Masi, G Allegrini, G Danesi, R Lencioni, M Pfanner, E Comis, S Del Tacca, M Conte, P
Citation: A. Falcone et al., Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients, J CL ONCOL, 19(15), 2001, pp. 3456-3462
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: A randomized phase II study in metastatic colorectal cancer
Authors: Falcone, A Allegrini, G Masi, G Lencioni, M Pfanner, E Brunetti, I Danesi, R Bocci, G Del Tacca, M Conte, P
Citation: A. Falcone et al., 5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: A randomized phase II study in metastatic colorectal cancer, ONCOL-BASEL, 61(1), 2001, pp. 28-35
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients
Authors: Bocci, G Danesi, R Di Paolo, A Innocenti, F Allegrini, G Falcone, A Melosi, A Battistoni, M Barsanti, G Conte, PF Del Tacca, M
Citation: G. Bocci et al., Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients, CLIN CANC R, 6(8), 2000, pp. 3032-3037
Prevention of cisplatin-induced delayed emesis: still unsatisfactory
Authors: Ruggeri, B Ballatori, E Roila, F De Angelis, V Tonato, M Del Favero, A Ciccarese, G Basurto, C Ciccarese, G Palladino, MA Porrozzi, S Picciafuoco, M Contu, SA Olmeo, N Pazzola, A Pilo, L Tateo, PS Salamano, S Morana, S Lucchino, S Ricci, S Antonuzzo, A Allegrini, G Galli, L Conte, PF Massidda, B Ionta, MT Scanu, A Murru, R Picece, V Nicodemo, M Recaldin, E Nuzzo, A Laudadio, L D'Ostilio, N Locatelli, MC D'Antona, A Luporini, G Scagliotti, G Selvaggi, G Mattei, A Favalli, G Gambino, A Fava, S Grimi, E Fava, S Grimi, E Scarfone, G Bolis, MC Alessandroni, P Catalano, G Boni, C Moretti, G Cortesi, E Martelli, O Antimi, M Bellini, V Buzzi, F Brugia, M Grecchi, G Clerico, M Montinari, F Donati, D Sansoni, E
Citation: B. Ruggeri et al., Prevention of cisplatin-induced delayed emesis: still unsatisfactory, SUPP CARE C, 8(3), 2000, pp. 229-232
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study
Authors: Lencioni, M Falcone, A Allegrini, G Pfanner, E Masi, G Brunetti, I Di Marsico, R Fontana, E Orlandini, C Stampino, CG Bartolozzi, C Conte, PF
Citation: M. Lencioni et al., Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study, ONCOL-BASEL, 59(3), 2000, pp. 204-209
A double-blind randomized study comparing intramuscular (i.m.) granisetronwith i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin
Authors: Conte, P Ricci, S Antonuzzo, A Allegrini, G Palazzo, S Liguori, V Mastroianni, C Manzione, L Bilancia, D Dinota, A Di Costanzo, F Gasperoni, S Sdrobolini, A Montinari, F Mastore, M Casartelli, C Danese, S Richiardi, G Sismondi, P Locatelli, MC D'Antona, A Luporini, G Ambrosini, G Giustini, L Bascioni, R Acito, L Recchia, F De Filippis, S Rosselli, M Vinante, O Rossetti, F Azzarello, G Lucenti, A Galligioni, E Brugnara, S Rossi, A al Vesuvio, SS Bumma, C Donadio, M Cattaneo, MT Aapro, MS Libretti, A Nole, F Bizzarri, M Facco, R Buzzi, F Brugia, M Colucci, G Giotta, F Manente, P Vicario, G Martoni, A Angelelli, B Pusceddu, G Salaris, G Comella, G Gravina, A Morrica, B Rampello, G Colosini, G Migliosi, G Temperilli, L Monno, D Amadori, D Maltoni, M Ammuni, G Villanucci, A Cocconi, G Bella, M Farris, A Sanna, G Gebbia, V Testa, A Iacono, G LoPresti, G Pergola, M Gridelli, C Adamo, V Altavilla, G Barbieri, P Pisoni, G
Citation: P. Conte et al., A double-blind randomized study comparing intramuscular (i.m.) granisetronwith i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin, ANTI-CANC D, 10(5), 1999, pp. 465-470
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study
Authors: Falcone, A Allegrini, G Lencioni, M Pfanner, E Brunetti, I Cianci, C Galli, C Masi, G Antonuzzo, A Conte, P
Citation: A. Falcone et al., Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study, CANC CHEMOT, 44(2), 1999, pp. 159-163
Infusions of fluorouracil and leucovorin: Effects of the timing and semi-intermittency of drug delivery
Authors: Falcone, A Allegrini, G Antonuzzo, A Brunetti, I Pfanner, E Lencioni, M Masi, G Danesi, R Del Tacca, M Conte, P
Citation: A. Falcone et al., Infusions of fluorouracil and leucovorin: Effects of the timing and semi-intermittency of drug delivery, ONCOL-BASEL, 57(3), 1999, pp. 195-201
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma
Authors: Falcone, A Antonuzzo, A Danesi, R Allegrini, G Monica, L Pfanner, E Masi, G Ricci, S Del Tacca, M Conte, P
Citation: A. Falcone et al., Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma, CANCER, 86(3), 1999, pp. 470-476
Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
Authors: Falcone, A Pfanner, E Brunetti, I Allegrini, G Lencioni, M Galli, C Masi, G Danesi, D Antonuzzo, A Del Tacca, M Conte, PF
Citation: A. Falcone et al., Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy, TUMORI, 84(6), 1998, pp. 666-668
Risultati: 1-11 |